Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2013
Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemiaSeiichiro Katagiri, Tetsuzo Tauchi, Seiichi Okabe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cellsTetsuzo Tauchi, Akihiro Nakajima, Goro Sashida, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2013
[Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia]Yuko Tanaka, Yoshikazu Ito, Sei-ichiro Yoshizawa, et al.Leukemia Research|January 9, 2018
Therapeutic effects of tyrosine kinase inhibitors and subtypes of BCR-ABL1 transcripts in Japanese chronic myeloid leukemia patients with three-way chromosomal translocationsKoiti Inokuchi, Kazutaka Nakayama, Tetsuzo Tauchi, et al.Stem Cells and Development|July 6, 2007
Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisisSeiichi Okabe, Tetsuzo Tauchi, Akihiro Nakajima, et al.Oncogene|August 15, 2003
Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathwaysTetsuzo Tauchi, Kazuo Shin-Ya, Goro Sashida, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 30, 2004
[Primary diffuse large B-cell lymphoma of the esophagus]Masahiko Sumi, Tomoiku Takaku, Tomotaka Iguchi, et al.International Journal of Molecular Sciences|April 20, 2016
Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of ImatinibKazuma Ohyashiki, Tomohiro Umezu, Seiichiro Katagiri, et al.Cancer Science|June 14, 2013
Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinibIzuru Mizoguchi, Takayuki Yoshimoto, Seiichiro Katagiri, et al.Leukemia Research|May 15, 2002
Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsyNahoko Shoji, Yoshikazu Ito, Yukihiko Kimura, et al.Pageof 8